Persivia, a provider of precision medicine and chronic care management solutions, has acquired Alere Analytics.
It said the move would enable them to help healthcare organizations better manage risk in today’s value-based purchasing environment.
The newly launched Persivia is dedicated to chronic care management, taking into account all patient data from clinical, claims, behavior, consumer, genomics and proteomic data to provide a quantum improvement in risk stratification, earlier interventions and control costs.
By acquiring Alere Analytics’ industry-leading, real-time population analytics, Persivia said it has added technology that will strengthen the company’s position in the precision medicine industry.
“Managing costs, especially around chronic diseases, is a top priority as more healthcare organizations take on and share the burden of risk in today’s new financial model of value-based purchasing,” said Mansoor Khan, chief executive officer of Persivia.
“Providers are at risk for a growing number of penalties from hospital-acquired infections (HAIs), medication management and re-admissions to managing chronically ill patients and all quality measures associated with those activities. With the acquisition of Alere Analytics, Persivia is well positioned to help our customers meet these challenges head on.”
Alere Analytics provides real-time clinical decision support (CDS) and chronic care management technologies. It deploys its analytics capabilities to provide real-time insights at the patient, network, provider and population level.
Persivia, Alere Analytics, Mergers & Acquisitions, US
